Study Shows New Drug Effective In Preventing HIV

A drug has been developed to be effective in the prevention of HIV infection. It is Truvada of Kaiser Permanente.

The vaccine comes after more than thirty years when the AIDS virus was first discovered.

The lab has tested the vaccine on more than 600 patients for about three years and says none of them have been tested positive. It is said the Truvada is effective in more than 90 percent cases.

According to a patient in the real-world trial of Kaiser Permanente in San Francisco, it is wonderful to worry less about the HIV disease as it always lurk in the back of his mind.

Doctor Jonathan Volk said they had first put the patients at risk for HIV and then on a daily regimen of Truvada that has been proven in clinic trials to be protective from HIV infection.

Truvada was approved in 2012 by US Food and Drug Administration (FDA) and the patients of Kaiser have been taking it since then.

Details of the study can be read in the Clinical Infectious Diseases online journal.

Director of the National Institute for Allergy and Infectious Diseases, Dr. Anthony S. Fauci, said the effectiveness of the drug is strikingly high. However, it is to see now how important it will be in fighting HIV down the line.

Currently only antiretroviral drugs are given to control the HIV virus in the body.

Other sexual infections are treated by giving antibiotics to the patients.

OTHER STORIES:
NYC Approves New Policies For Healthier Fast Food For Children
Noon Nap Helps Reduce Blood Pressure Levels: Study

PREVIOUS STORIES:
WHO To Vaccinate 200 In Sierra Leone To Prevent Ebola
Lenvo Unveils Moto 360 Smartwatch At IFA Technology Show In Berlin